Could cause temporary or reversible harm; serious harm is unlikely.
Failed stability specifications: Out of specification for hardness test
| Brand name | LANTHANUM CARBONATE |
| Generic name | LANTHANUM CARBONATE |
| Active ingredient(s) | LANTHANUM CARBONATE |
| Distributed by / for | Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059 |
| NDC | 69097-936-98 |
| Full product label | Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98. |
| Recalling firm | Cipla USA, Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 1180 boxes |
| Recall initiated | 2025-10-24 |
| Report date | 2025-12-17 |
| Recall completed | — |
| Recall number | D-0217-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗